CLINICAL_TRIALS
trial_result
· 2018-08-27
Clinical Trial Update: Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia [Phase 3]
Summary
Phase 3 trial update for moxetumomab pasudotox in advanced hairy cell leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Leukemia, Hairy Cell | Phase 3 | Status: COMPLETED | Results posted: 2018-08-27